Log in

6794 UnicoCell Biomed Co., Ltd. TWSE · Taiwan

UnicoCell Biomed Co. (6794) news

UnicoCell Biomed Co., Ltd. is a public biotech or pharmaceutical company listed on TWSE under the ticker 6794, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest UnicoCell Biomed Co. news

We have not published a story on UnicoCell Biomed Co. yet. When there is news, it will appear here.

Questions about UnicoCell Biomed Co.

What is the ticker symbol of UnicoCell Biomed Co.?

UnicoCell Biomed Co., Ltd. trades under the ticker 6794 on TWSE.

Where is UnicoCell Biomed Co. listed?

UnicoCell Biomed Co., Ltd. is listed on TWSE.

Which country or territory is UnicoCell Biomed Co. listed under?

Our directory records UnicoCell Biomed Co., Ltd. under Taiwan.

What does UnicoCell Biomed Co. do?

Our directory classifies UnicoCell Biomed Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of UnicoCell Biomed Co.?

The ISIN recorded for UnicoCell Biomed Co., Ltd. is TW0006794001.

Does aibio.space cover UnicoCell Biomed Co.?

aibio.space lists UnicoCell Biomed Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to UnicoCell Biomed Co.?

Companies in our directory listed in the same country and business area as UnicoCell Biomed Co.: Bioptic, Enimmune corporation, PELL Bio-Med Technology Co, TaiwanJ Pharmaceuticals Co., Lukas biomedical, Locus Cell Co..

Investor discussion: UnicoCell Biomed Co.

Members talk about UnicoCell Biomed Co. (6794). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TWSE:6794 on TradingView.

Listing details

UnicoCell Biomed Co., Ltd. is a public biotech or pharmaceutical company listed on TWSE under the ticker 6794, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
UnicoCell Biomed Co., Ltd.
Ticker
6794
Listing
TWSE
Country or territory
Taiwan
Business scope
Biotechnology
ISIN
TW0006794001
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.